KindlyMD, Inc. (NASDAQ:NAKA) Short Interest Up 45.0% in October

KindlyMD, Inc. (NASDAQ:NAKA) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 13,950,000 shares, an increase of 45.0% from the September 30th total of 9,620,000 shares. Based on an average daily volume of 16,160,000 shares, the days-to-cover ratio is presently 0.9 days. Approximately 3.7% of the shares of the stock are short sold. Approximately 3.7% of the shares of the stock are short sold. Based on an average daily volume of 16,160,000 shares, the days-to-cover ratio is presently 0.9 days.

KindlyMD Stock Performance

Shares of NASDAQ NAKA opened at $0.93 on Monday. The firm has a market capitalization of $401.26 million, a P/E ratio of -1.08 and a beta of 30.76. KindlyMD has a 12 month low of $0.65 and a 12 month high of $34.77. The business’s 50-day simple moving average is $2.34.

KindlyMD (NASDAQ:NAKA) last issued its earnings results on Tuesday, August 5th. The company reported ($0.34) EPS for the quarter. The business had revenue of $0.41 million for the quarter. KindlyMD had a negative return on equity of 131.09% and a negative net margin of 244.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on NAKA shares. Zacks Research raised shares of KindlyMD to a “hold” rating in a report on Friday, October 17th. Maxim Group initiated coverage on shares of KindlyMD in a research note on Wednesday, September 3rd. They set a “buy” rating and a $8.00 price objective on the stock. B. Riley started coverage on shares of KindlyMD in a report on Wednesday, October 15th. They set a “buy” rating and a $2.00 target price on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of KindlyMD in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a report on Saturday, October 18th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $5.00.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.